Stay updated on Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. This is a minor version update with no visible changes to the study content.
    Difference
    0.1%
    Check dated 2026-01-14T01:47:30.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Footer updates include the addition of 'Revision: v3.3.3' and the removal of the 'HHS Vulnerability Disclosure' link along with the earlier 'Revision: v3.3.2' label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T10:13:16.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Added a note that publications are auto-filled from PubMed and updated the revision to v3.3.2; the previous PubMed-origin note and v3.2.0 revision were removed.
    Difference
    0.1%
    Check dated 2025-11-24T16:51:55.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice from the page. The study details, eligibility criteria, and outcomes remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T14:59:33.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    No substantive changes detected in the study record between the two screenshots. The page continues to display the same study title, conditions, eligibility criteria, and planned interventions.
    Difference
    0.5%
    Check dated 2025-11-03T01:30:54.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    4%
    Check dated 2025-10-05T10:18:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page.